This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The HeartRhythm Society (HRS) is preparing for HRX 2024, the third annual event of its kind, which will be held from September 5-7, 2024, in Atlanta, GA, gathering cardiovascular health innovators together to explore discoveries and advance partnerships between medicine and technology. On Thursday, Sept.
During its Annual Conference, HRS 2024, the HeartRhythm Society (HRS) announced findings from three new studies demonstrating the safety and efficacy of pulsed field ablation (PFA), a nonthermal ablation treatment for patients with atrial fibrillation (AF). director of electrophysiology, Mount Sinai Fuster Heart Hospital , New York.
milla1cf Tue, 06/11/2024 - 18:09 June 11, 2024 — Stereotaxis (NYSE: STXS), a pioneer in surgical robotics for minimally invasive endovascular intervention, today announced that Hospital Santa Maria della Pietà, in Nola in the Metropolitan City of Naples, has established the first robotic cardiac heart program in Southern Italy.
milla1cf Thu, 01/18/2024 - 14:21 January 18, 2024 — Abbott announced the first global procedures have been conducted using the company's new Volt Pulsed Field Ablation (PFA) System to treat patients battling common abnormal heartrhythms such as atrial fibrillation (AFib). chief medical officer of Abbott's electrophysiology business.
A pacemaker modified for newborns' tiny bodies safely and effectively stabilized their heartrhythms for up to two years, according to new research published in Circulation: Arrhythmia and Electrophysiology.
Four heartrhythm organizations from around the globe developed the statement. It is also published in HeartRhythm , the official journal of the HRS, Journal of Arrhythmia , the official journal of the APHRS, and Journal of Interventional Cardiac Electrophysiology , the official journal of the LAHRS.
The robotic technology represented an entirely novel way to address heartrhythm disorders in a minimally invasive procedure with the benefits of robotic precision and safety. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.
milla1cf Tue, 05/21/2024 - 08:00 May 21, 2024 — Stereotaxis , a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has been invited to present at HRS Africa Summit 2024 , scheduled to take place during HeartRhythm Society Scientific Sessions in Boston, Massachusetts.
Two articles and an accompanying editorial in HeartRhythm , the official journal of the HeartRhythm Society, the Cardiac Electrophysiology Society , and the Pediatric & Congenital Electrophysiology Society , published by Elsevier , address the controversy and recommend shortening the blanking period.
milla1cf Fri, 01/19/2024 - 10:38 January 19, 2024 — Heartrhythm expert Sumeet Chugh, MD , associate director of the Smidt Heart Institute at Cedars-Sinai , is the recipient of this year’s American College of Cardiology ( ACC ) Distinguished Scientist Award-Clinical Domain. “I Photo by Cedars-Sinai.
UC San Diego Health is the first in San Diego to successfully implant the world’s first dual chamber and leadless pacemaker system to help treat people with abnormal heartrhythms. The most common arrhythmia, atrial fibrillation , will affect approximately 12.1
Volta Medical has announced it has entered into a Joint Development Agreement with GE Healthcare to enhance arrhythmia procedures with artificial intelligence (AI)-driven electrophysiology technologies. Our mission to combat complex heartrhythm diseases relies on optimizing interoperability.
In electrophysiology, innovation is king, but it is often incremental, and it almost always lacks rationale, comprehensive clinical documentation and relevance for hospitals that try to balance the increasing costs of new technology with increasing demand and reimbursement that just can’t keep pace.
Circulation: Arrhythmia and Electrophysiology, Ahead of Print. In 490 full-text EHR notes from 125 patients with prior life-threatening heartrhythm disorders, we asked GPT-4-turbo to identify recurrent arrhythmias distinct from prior events and tested 220 563 queries.
Unlike paroxysmal AF, which describes symptoms that last for seven days or fewer, persistent AF is a sustained arrhythmia that lasts for more than a week 1. Early treatment of persistent AF can reduce the risk of blood clots, stroke, and heart failure, and may prevent the disease from becoming permanent.
Atrial fibrillation (AF) is the most common arrhythmia worldwide, with increasing prevalence resulting from improved awareness, increased life expectancy, and advances in detection technology.
On January 7, 2024, our cardiac electrophysiology community lost Bruce L. Wilkoff, MD, one of the most impactful and pioneering members of the HeartRhythm Society (HRS). Dr Wilkoff was an innovator in the field of cardiac implantable electronic devices (CIEDs).
Massie Block -Ref 1) But, if there is something unusual in the clinical history, be ready to investigate until the arrhythmia, or at least the anxiety disappears. Clinical and electrophysiologic findings in patients with paroxysmal slowing of the sinus rate and apparent Mobitz type II atrioventricular block. Reference 1. PMID: 668079.
The Smidt Heart Institute recently received CAROL Act funding to study the connection between ventricular arrhythmias—abnormal heartbeats that start in the heart’s two lower chambers—and an elevated risk of sudden cardiac death in patients with mitral valve disease.
I am starting this sitting here in my hotel room at APHRS in Hong Kong so impressed with the global world of electrophysiology (EP) and the common language we all speak.
Journal of Cardiovascular Electrophysiology, Volume 30, Issue 10, October 2019, Pages 1994–2001. Eur Heart J. The role of atrial sensing for new-onset atrial arrhythmias diagnosis and management in single-chamber implantable cardioverter-defibrillator recipients: Results from the THINGS registry. January CT, et al.
European HeartRhythm Association (EHRA) Congress Date: April 7-9, 2024 Location: Berlin, Germany and online Overview: The yearly gathering of the European HeartRhythm Association (EHRA) unites scientists, healthcare professionals, and other stakeholders engaged in the global management of arrhythmias.
Prior to Mizusawa's study, it was thought that the incidence of syncope, arrhythmia, or SCD in this cohort was low [7]. In light of the risk of arrhythmia events observed in the Mizusawa trial, a formal EP study might be reasonable to obtain in those with fever induced asymptomatic Brugada ECG changes to help risk stratify these patients.
Brugada Syndrome: Diagnosis and Risk Stratification Hello friends, this is the modified version of my talk at Indian HeartRhythm Society Conference, New Delhi, 2023, on Brugada Syndrome. This is the proposed mechanism of precipitation of arrhythmias in Brugada syndrome during febrile episodes. Hope you will enjoy this session.
a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTech , today announced European CE mark approval of the VARIPULSE Platform for the treatment of symptomatic drug refractory recurrent paroxysmal atrial fibrillation ( AF ) using pulsed field ablation (PFA). [ii]
Atrial fibrillation, or AFib, is the most common type of heartrhythm disorder (arrhythmia), affecting over 6 million Americans, and the number is expected to double by 2030. Catheter ablation is a minimally invasive procedure that disables portions of heart tissue that cause irregular heartrhythms. “In
Prior to Mizusawa's study, it was thought that the incidence of syncope, arrhythmia, or SCD in this cohort was low [7]. In light of the risk of arrhythmia events observed in the Mizusawa trial, a formal EP study might be reasonable to obtain in those with fever induced asymptomatic Brugada ECG changes to help risk stratify these patients.
Since it was announced as a Class 1A recommendation in 2015 by the HeartRhythm Society, cardiac remote patient monitoring has become the standard of care for cardiac device patients. Cardiac implantable devices are sophisticated technology that provide both therapy and diagnostics for patients with irregular heartrhythms.
EDT, the ACC will present Sumeet Chugh, MD , associate director of the Smidt Heart Institute, with this year’s Distinguished Scientist Award-Clinical Domain. EDT, and she will co-chair electrophysiology research presentations. She also will serve as a panelist on the Eugene Braunwald Keynote, Monday, April 8, 1:30-2 p.m.
A score including ECG pattern, early familial SCD antecedents, inducible electrophysiological study, presentation as syncope or as aborted SCD and SND had a predictive performance of 0.82. Conclusion of this paper: Fever is a great risk factor for arrhythmia events in Brugada Syndrome patients. HeartRhythm 2016.
He was discharged with an event monitor and electrophysiology follow up. HeartRhythm , 6 (8), 12291234. link] == MY Comment , by K EN G RAUER, MD ( 2/2 /2025 ): == Enlightening case by Dr. Figure-1: I've labeled today's continuous rhythm strip. What do you think? The North American Vasovagal Pacemaker Study (VPS).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content